A Novel role for type 1 angiotensin receptors on T lymphocytes to limit target organ damage in hypertension

Circulation Research

Volumn 110, Issue 12, 2012, Pages 1604-1617

  Zhang, Jian Dong ^a   Patel, Mehul B ^a   Song, Young Soo ^a   Griffiths, Robert ^a   Burchette, James ^b   Ruiz, Phillip ^c   Sparks, Matthew A ^a   Yan, Ming ^a   Howell, David N ^b   Gomez, Jose A ^a   Spurney, Robert F ^a   Coffman, Thomas M ^a   Crowley, Steven D ^a  

^a Division of Nephrology   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Hypertension; Inflammation; Kidney disease; T lymphocytes

Indexed keywords

ANGIOTENSIN RECEPTOR; CHEMOKINE; GAMMA INTERFERON; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; HYPERTENSION; KIDNEY INJURY; KNOCKOUT MOUSE; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TARGET ORGAN; TH1 CELL; TH2 CELL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; HYPERTENSION; KIDNEY; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 84862296510     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.111.261768     Document Type: Article

References (49)

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913. (Pubitemid 35472129)
2. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (life): A randomised trial against atenolol. Lancet. 2002;359:995-1003. (Pubitemid 34286536)
3. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:861-869.
4. Muller DN, Shagdarsuren E, Park JK, et al. Immunosuppressive treatment protects against angiotensin ii-induced renal damage. Am J Pathol. 2002; 161:1679-1693. (Pubitemid 35265527)
5. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG. Role of the t cell in the genesis of angiotensin ii induced hypertension and vascular dysfunction. J Exp Med. 2007;204:2449-2460. (Pubitemid 47529329)
6. Crowley SD, Song Y-S, Lin EE, Griffiths R, Kim H-S, Ruiz P. Lymphocyte responses exacerbate angiotensin ii-dependent hypertension. Am J Physiol Regul Integr Comp Physiol. 2010;298:R1089-R1097.
7. Hisada Y, Sugaya T, Tanaka S, Suzuki Y, Ra C, Kimura K, Fukamizu A. An essential role of angiotensin ii receptor type 1a in recipient kidney, not in transplanted peripheral blood leukocytes, in progressive immunemediated renal injury. Lab Invest. 2001;81:1243-1251. (Pubitemid 32911973)
8. Nishida M, Fujinaka H, Matsusaka T, Price J, Kon V, Fogo AB, Davidson JM, Linton MF, Fazio S, Homma T, Yoshida H, Ichikawa I. Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. J Clin Invest. 2002;110:1859-1868. (Pubitemid 36076493)
9. Kato H, Ishida J, Nagano K, Honjo K, Sugaya T, Takeda N, Sugiyama F, Yagami K, Fujita T, Nangaku M, Fukamizu A. Deterioration of atherosclerosis in mice lacking angiotensin ii type 1a receptor in bone marrowderived cells. Lab Invest. 2008;88:731-739. (Pubitemid 351896638)
10. Lu H, Rateri DL, Feldman DL, Jr, Fukamizu A, Ishida J, Oesterling EG, Cassis LA, Daugherty A. Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice. J Clin Invest. 2008;118:984-993. (Pubitemid 351364606)
11. Kuin A, Kruse JJ, Stewart FA. Proteinuria and vascular changes after renal irradiation: The role of reactive oxygen species (ROS) and vascular endothelial growth factor (VEGF). Radiat Res. 2003;159:174-181. (Pubitemid 36182395)
12. Ehninger A, Trumpp A. The bone marrow stem cell niche grows up: Mesenchymal stem cells and macrophages move in. J Exp Med. 2011; 208:421-428.
13. Nataraj C, Oliverio MI, Mannon RB, Mannon PJ, Audoly LP, Amuchastegui CS, Ruiz P, Smithies O, Coffman TM. Angiotensin ii regulates cellular immune responses through a calcineurin-dependent pathway. J Clin Invest. 1999;104:1693-1701. (Pubitemid 30053186)
14. Gurley SB, Riquier-Brison AD, Schnermann J, Sparks MA, Allen AM, Haase VH, Snouwaert JN, Le TH, McDonough AA, Koller BH, Coffman TM. At(1a) angiotensin receptors in the renal proximal tubule regulate blood pressure. Cell Metab. 2011;13:469-475.
15. Lee PP, Fitzpatrick DR, Beard C, et al. A critical role for dnmt1 and DNA methylation in t cell development, function, and survival. Immunity. 2001;15:763-774. (Pubitemid 34008504)
16. Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L. A global doublefluorescent cre reporter mouse. Genesis. 2007;45:593-605. (Pubitemid 350013057)
17. Crowley SD, Gurley SB, Oliverio MI, Pazmino AK, Griffiths R, Flannery PJ, Spurney RF, Kim HS, Smithies O, Le TH, Coffman TM. Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest. 2005;115:1092-1099. (Pubitemid 40489414)
18. Wang L, Chang JH, Paik SY, Tang Y, Eisner W, Spurney RF. Calcineurin (cn) activation promotes apoptosis of glomerular podocytes both in vitro and in vivo. Mol Endocrinol. 2011;25:1376-1386.
19. Mannon RB, Kotzin BL, Nataraj C, Ferri K, Roper E, Kurlander RJ, Coffman TM. Downregulation of t cell receptor expression by cd8(r) lymphocytes in kidney allografts. J Clin Invest. 1998;101:2517-2527. (Pubitemid 28270446)
20. Crowley SD, Vasievich MP, Ruiz P, et al. Glomerular type 1 angiotensin receptors augment kidney injury and inflammation in murine autoimmune nephritis. J Clin Invest. 2009;119:943-953.
21. Lautrette A, Li S, Alili R, Sunnarborg SW, Burtin M, Lee DC, Friedlander G, Terzi F. Angiotensin ii and egf receptor cross-talk in chronic kidney diseases: A new therapeutic approach. Nat Med. 2005;11: 867-874. (Pubitemid 41161119)
22. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM. Angiotensin ii causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci USA. 2006;103:17985-17990. (Pubitemid 44852272)
23. De Miguel C, Das S, Lund H, Mattson DL. T lymphocytes mediate hypertension and kidney damage in dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol. 2010;298:R1136-R1142.
24. Paragas N, Qiu A, Zhang Q, et al. The ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med. 2011;17:216-222.
25. Ozawa Y, Kobori H, Suzaki Y, Navar LG. Sustained renal interstitial macrophage infiltration following chronic angiotensin ii infusions. Am J Physiol Renal Physiol. 2007;292:F330-F339. (Pubitemid 46105273)
26. Ramesh G, Reeves WB. Tnf-{alpha} mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest. 2002;110:835-842.
27. Balomenos D, Rumold R, Theofilopoulos AN. Interferon-gamma is required for lupus-like disease and lymphoaccumulation in mrl-lpr mice. J Clin Invest. 1998;101:364-371. (Pubitemid 28067333)
28. Thabet SR, Wu J, Chen W, Marvar PJ, Gongora MC, Madhur MS, Blinder Y, Weyand C, Harrison DG. The role of cd8t cells, ip-10 and mmp12 in hypertension. Hypertension. 2011;58:e49 Abstract.
29. Liao TD, Yang XP, Liu YH, Shesely EG, Cavasin MA, Kuziel WA, Pagano PJ, Carretero OA. Role of inflammation in the development of renal damage and dysfunction in angiotensin ii-induced hypertension. Hypertension. 2008;52:256-263.
30. Rudolph EH, Congdon KL, Sackey FN, Fitzsimons MM, Foster MH. Humoral autoimmunity to basement membrane antigens is regulated in c57bl/6 and mrl/mpj mice transgenic for anti-laminin ig receptors. J Immunol. 2002;168:5943-5953. (Pubitemid 34556185)
31. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, t-bet, directs th1 lineage commitment. Cell. 2000;100:655-669.
32. Chakir H, Wang H, Lefebvre DE, Webb J, Scott FW. T-bet/gata-3 ratio as a measure of the th1/th2 cytokine profile in mixed cell populations: Predominant role of gata-3. J Immunol Methods. 2003;278:157-169. (Pubitemid 37281199)
33. Sun Q, Cheng D, Zhang M, He Q, Chen Z, Liu Z. Predominance of intraglomerular t-bet or gata3 may determine mechanism of transplant rejection. J Am Soc Nephrol. 2011;22:246-252.
34. Fourcade J, Sun Z, Benallaoua M, Guillaume P, Luescher IF, Sander C, Kirkwood JM, Kuchroo V, Zarour HM. Upregulation of tim-3 and pd-1 expression is associated with tumor antigen-specific cd8t cell dysfunction in melanoma patients. J Exp Med. 2010;207:2175-2186.
35. Hoch NE, Guzik TJ, Chen W, Deans T, Maalouf SA, Gratze P, Weyand C, Harrison DG. Regulation of t-cell function by endogenously produced angiotensin ii. Am J Physiol Regul Integr Comp Physiol. 2009;296: R208-R216.
36. Crowley SD, Frey CW, Gould SK, Griffiths R, Ruiz P, Burchette JL, Howell DN, Makhanova N, Yan M, Kim H-S, Tharaux P-L, Coffman TM. Stimulation of lymphocyte responses by angiotensin ii promotes kidney injury in hypertension. Am J Physiol Renal Physiol. 2008;295: F515-F524.
37. Crowley SD, Song YS, Sprung G, Griffiths R, Sparks M, Yan M, Burchette JL, Howell DN, Lin EE, Okeiyi B, Stegbauer J, Yang Y, Tharaux PL, Ruiz P. A role for angiotensin ii type 1 receptors on bone marrow-derived cells in the pathogenesis of angiotensin ii-dependent hypertension. Hypertension. 2010;55:99-108.
38. Nahmod KA, Geffner JR, Walther T. Angiotensin II type 1a-deficient bone marrow-derived dendritic cells produce higher levels of monocyte chemoattractant protein 1. Hypertension. 2010;56:e6-e7; author reply e8.
39. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421-426. (Pubitemid 32681484)
40. Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio MR, Nicocia G, Buemi M. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:337-344.
41. Eddy AA. Progression in chronic kidney disease. Adv Chronic Kidney Dis. 2005;12:353-365. (Pubitemid 41376493)
42. Strom TB, Koulmanda M. Recently discovered T cell subsets cannot keep their commitments. J Am Soc Nephrol. 2009;20:1677-1680.
43. Wherry EJ. T cell exhaustion. Nat Immunol. 2011;12:492-499.
44. Mitchell JS, Kanca O, McIntyre BW. Lipid microdomain clustering induces a redistribution of antigen recognition and adhesion molecules on human t lymphocytes. J Immunol. 2002;168:2737-2744. (Pubitemid 34211651)
45. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, Koch AE, Moser B, Mackay CR. The chemokine receptors cxcr3 and ccr5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest. 1998;101:746-754. (Pubitemid 28096070)
46. Phoon RK, Kitching AR, Odobasic D, Jones LK, Semple TJ, Holdsworth SR. T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis. J Am Soc Nephrol. 2008;19:477-485. (Pubitemid 351355391)
47. Bertani T, Abbate M, Zoja C, Corna D, Perico N, Ghezzi P, Remuzzi G. Tumor necrosis factor induces glomerular damage in the rabbit. Am J Pathol. 1989;134:419-430. (Pubitemid 19063898)
48. Sriramula S, Haque M, Majid DSA, Francis J. Involvement of tumor necrosis factor-{alpha} in angiotensin ii-mediated effects on salt appetite, hypertension, and cardiac hypertrophy. Hypertension. 2008;51: 1345-1351. (Pubitemid 351555948)
49. Crowley SD, Zhang J, Herrera M, Griffiths R, Ruiz P, Coffman TM. Role of at1 receptor-mediated salt retention in angiotensin ii-dependent hypertension. Am J Physiol Renal Physiol. 2011;301:F1124-F1130.